7,595 active funding opportunities
Supports development of VR/AR simulations and digital training to improve readiness and response for large-scale cross-border disasters.
Supports rapid development of detection and investigation tools to combat evolving online harms with active Police Authority collaboration.
Supports projects developing evidence-based prevention, treatment, harm reduction, and anti-trafficking strategies for synthetic drugs and stimulants in Europe.
Supports projects developing AI-driven decision support systems to improve civil preparedness and crisis response using real-time data and advanced analytics.
Supports projects improving physical security and resilience of critical infrastructures against emerging threats using innovative and nature-based solutions.
Supports renewal of existing NINDS clinical trial cooperative agreements needing more time and resources to complete trials.
Funds early-stage development of novel Alzheimer's drug candidates including pre-clinical studies and Phase I trials.
Supports HIV/AIDS research aligned with NIDDK mission and NIH HIV/AIDS priorities, clinical trial optional.
Supports development of computational tools and models to analyze dynamic brain circuits and advance brain disorder treatments.
Apply for the 2027-2028 US Fellowship Program; application due November 12, 2027.
Funds established investigators to build research capacity and mentorship in aging and Alzheimer's Disease without leading independent clinical trials.
Supports NINDS intramural neurologist- and neurosurgeon-scientists transitioning to independent research and clinical faculty roles.
Supports neurologist- and neurosurgeon-scientists transitioning from NIH intramural roles to independent academic research and clinical positions.
Supports innovative multisite clinical trials leveraging NICHD Network infrastructure focused on women, children, pregnant and lactating women, and persons with disabilities.
Funds advanced pre-clinical research on nanotechnology-based cancer diagnostics and therapeutics to improve treatment effectiveness.
Funds research on novel newborn screening methods and therapies for fatal or disabling conditions, including emerging genetic disorders.
Funds pilot projects to study understudied proteins linked to rare diseases, supporting preliminary data and tool development.
Funds innovative basic research on biological/genetic causes of cancer health disparities, including mechanistic studies and new methodologies.
Supports research on novel newborn screening methods and therapies for fatal or disabling conditions, including high priority genetic disorders.
Funds pilot research on biological, behavioral, and social mechanisms contributing to HIV pathogenesis within NIDDK's mission, excluding clinical trials.
Funds research on the harmful effects and delayed impacts of acute exposure to ultra-potent synthetic opioids like fentanyl and carfentanil.
Supports foundational research proposals in basic, applied, and advanced technology development for Army overmatch in future conflicts.
